Search

Abstract Introduction The integrated care pathways for atopic dermatitis (AD‐ICPs) aim to bridge the gap between existing AD treatment evidence‐based guidelines and expert opinion based on daily practice by offering a structured multidisciplinary plan for patient management of AD. ICPs have the potential to enhance guideline recommendations by combining interventions and aspects from different guidelines, integrating quality assurance, and describing co‐ordination of care. Most importantly, patients can enter the ICPs at any level depending on AD severity, resources available in their country, and economic factors such as differences in insurance reimbursement systems. Methods The GA2LEN ADCARE network and partners as well as all stakeholders, abbreviated as the AD‐ICPs working group, were involved in the discussion and preparation of the AD ICPs during a series of subgroup workshops and meetings in years 2020 and 2021, after which the document was circulated within all GAL2EN ADCARE centres. Results The AD‐ICPs outline the diagnostic procedures, possible co‐morbidities, different available treatment options including differential approaches for the pediatric population, and the role of the pharmacists and other stakeholders, as well as remaining unmet needs in the management of AD. Conclusion The AD‐ICPs provide a multidisciplinary plan for improved diagnosis, treatment, and patient feedback in AD management, as well as addressing critical unmet needs, including improved access to care, training specialists, implementation of educational programs, assessment on the impact of climate change, and fostering a personalised treatment approach. By focusing on these key areas, the initiative aims to pave the way for a brighter future in the management of AD.

Background: The prevalence of atopic dermatitis (AD) is increasing in developing countries. Different worldwide guidelines have been proposed, but their applicability for AD specialists in Latin American (LA) countries is unknown. Objective: The objective of this study was to explore the medical approach to treating AD in LA countries. Methods: The study population comprised AD specialists (allergists and dermatologists). They completed an electronic survey containing questions about the health system, diagnostic criteria, and pharmacotherapy approach to treating AD. The survey was constructed and validated by the Atopic Dermatitis Committee of the Latin American Society of Allergy Asthma and Immunology (SLAAI) in Spanish and Portuguese. Each member was responsible for distributing the questionnaire through different networks in their respective countries. Results: A total of 284 AD specialists from 13 LA countries completed the questionnaire; among them, 67% were allergists and 33% were dermatologists. Less than 50% of the AD specialists strictly followed guideline recommendations. Among the AD specialists, the European and North American guidelines were more frequently used, and only 16% followed LA guidelines. Dermatologists used the local guidelines less frequently than allergists. Most physicians did not routinely use AD assessment tools (55%). The frequency of the diagnostic tests depends on symptom severity. The availability of some systemic treatments, such as biologics and Janus Kinase (JAK) inhibitors, is not universal in all LA countries. Conclusion: There were marked differences between the specialists, and these differences seemed to be affected by their specialty and each country's healthcare system. New AD education strategies that consider the particularities of the region could allow patients to be more accurately managed. AD assessment tools may provide a way to enhance AD treatment and allow for shared decision-making, patient empowerment, and standardized care.

Este trabalho objetivou estimar as exigências nutricionais de energia metabolizável (EM) e lisina digestível (LD) para codornas Japonesas nas fases de cria (1 a 14 dias) e recria (15 a 42 dias) e verificar suas implicações na composição química corporal, peso relativo dos órgãos, parâmetros sanguíneos e ósseos. O delineamento adotado foi o inteiramente casualizado em esquema fatorial 4 x 4 (EM = 2.830, 2.970, 3.110 e 3.250 kcal x LD = 0,90; 1,07; 1,24 e 1,41%), perfazendo 16 tratamentos com 3 repetições cada, contendo 50 codornas por unidade experimental na fase de cria (totalizando 2.400 aves) e 35 codornas por unidade experimental na fase de recria (totalizando 1.680 aves). Não foi verificada interação entre os fatores sobre o desempenho de codornas Japonesas na fase de cria, sendo que as variáveis peso médio, ganho de peso, consumo de ração e conversão alimentar apresentaram efeito quadrático tanto para EM quanto para LD. Nesta fase, o extrato etéreo da carcaça e o índice de Seedor do fêmur e da tíbia exibiram interação significativa, e o peso relativo do fígado apresentou efeito linear da LD. Na fase de recria houve interação dos fatores para ganho de peso e consumo de ração. A conversão alimentar apresentou efeito quadrático de ambos os fatores e o peso médio foi influenciado de modo quadrático pela EM, que também influenciou de modo quadrático o índice de Seedor nos dois ossos e a densidade óssea do fêmur. Considerando as estimativas obtidas por meio dos gráficos de contornos sobrepostos, os níveis de 3.030 kcal de EM e 1,221% de LD foram estimados para a fase de cria e os níveis de 3.055 kcal de EM e 1,202% de LD foram estimados para a fase de recria.